A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

Adams, 2008, Is tumor growth sustained by rare cancer stem cells or dominant clones?, Cancer Res., 68, 4018, 10.1158/0008-5472.CAN-07-6334 Balint, 2005, Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression, J. Clin. Invest., 115, 3166, 10.1172/JCI25001 Blagosklonny, 2005, Why therapeutic response may not prolong the life of a cancer patient: selection for oncogenic resistance, Cell Cycle, 4, 1693, 10.4161/cc.4.12.2259 Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730 Christensen, 2007, RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3, Cell, 128, 1063, 10.1016/j.cell.2007.02.003 Clarke, 2006, Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res, 66, 9339, 10.1158/0008-5472.CAN-06-3126 Dey, 2008, The histone demethylase KDM5b/JARID1b plays a role in cell fate decisions by blocking terminal differentiation, Mol. Cell. Biol., 17, 5312, 10.1128/MCB.00128-08 Fang, 2005, A tumorigenic subpopulation with stem cell properties in melanomas, Cancer Res., 65, 9328, 10.1158/0008-5472.CAN-05-1343 Gogas, 2007, Chemotherapy for metastatic melanoma: time for a change?, Cancer, 109, 455, 10.1002/cncr.22427 Goodell, 1996, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, J. Exp. Med., 183, 1797, 10.1084/jem.183.4.1797 Grichnik, 2006, Melanoma, a tumor based on a mutant stem cell?, J. Invest. Dermatol., 126, 142, 10.1038/sj.jid.5700017 Guenther, 2007, A chromatin landmark and transcription initiation at most promoters in human cells, Cell, 130, 77, 10.1016/j.cell.2007.05.042 Iwase, 2007, The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases, Cell, 128, 1077, 10.1016/j.cell.2007.02.017 Kageyama, 2009, Rhythmic gene expression in somite formation and neural development, Mol. Cells, 27, 497, 10.1007/s10059-009-0068-1 Kageyama, 2008, Dynamic Notch signaling in neural progenitor cells and a revised view of lateral inhibition, Nat. Neurosci., 11, 1247, 10.1038/nn.2208 Kelly, 2007, Tumor growth need not be driven by rare cancer stem cells, Science, 317, 337, 10.1126/science.1142596 Klose, 2007, The retinoblastoma binding protein RBP2 is an H3K4 demethylase, Cell, 128, 889, 10.1016/j.cell.2007.02.013 Krivtsov, 2007, MLL translocations, histone modifications and leukaemia stem-cell development, Nat. Rev. Cancer, 7, 823, 10.1038/nrc2253 Liu, 2006, Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression, Cancer Res., 66, 4182, 10.1158/0008-5472.CAN-05-3589 Lu, 1999, A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer, J. Biol. Chem., 274, 15633, 10.1074/jbc.274.22.15633 Macaluso, 2006, Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes, Oncogene, 25, 5263, 10.1038/sj.onc.1209680 Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 Monzani, 2007, Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential, Eur. J. Cancer, 43, 935, 10.1016/j.ejca.2007.01.017 Moriyama, 2006, Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells, J. Cell Biol., 173, 333, 10.1083/jcb.200509084 Pinnix, 2009, Active Notch1 confers a transformed phenotype to primary human melanocytes, Cancer Res., 69, 5312, 10.1158/0008-5472.CAN-08-3767 Quintana, 2008, Efficient tumour formation by single human melanoma cells, Nature, 456, 593, 10.1038/nature07567 Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Roesch, 2005, Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas, Mod. Pathol., 18, 1249, 10.1038/modpathol.3800413 Roesch, 2006, Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells, J. Invest. Dermatol., 126, 1850, 10.1038/sj.jid.5700324 Roesch, 2008, RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells, Int. J. Cancer, 122, 1047, 10.1002/ijc.23211 Satyamoorthy, 1997, Melanoma cell lines from different stages of progression and their biological and molecular analyses, Melanoma Res., 7, S35 Schatton, 2008, Identification of cells initiating human melanomas, Nature, 451, 345, 10.1038/nature06489 Scibetta, 2007, Functional analysis of the transcription repressor PLU-1/JARID1B, Mol. Cell. Biol., 27, 7220, 10.1128/MCB.00274-07 Singh, 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res., 63, 5821 Takeuchi, 2006, Roles of jumonji and jumonji family genes in chromatin regulation and development, Dev. Dyn., 235, 2449, 10.1002/dvdy.20851 Tan, 2003, Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9, J. Biol. Chem., 278, 20507, 10.1074/jbc.M301994200 Vogt, 1999, Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer, Lab. Invest., 79, 1615 Wong, 2006, Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin, J. Cell Biol., 175, 1005, 10.1083/jcb.200606062 Wright, 2008, Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics, Breast Cancer Res., 10, R10, 10.1186/bcr1855 Xia, 2009, Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis, Proc. Natl. Acad. Sci. USA, 106, 4260, 10.1073/pnas.0810067106 Yamane, 2007, PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation, Mol. Cell, 25, 801, 10.1016/j.molcel.2007.03.001 Zabierowski, 2008, Melanoma stem cells: the dark seed of melanoma, J. Clin. Oncol., 26, 2890, 10.1200/JCO.2007.15.5465 Barrett, A., Madsen, B., Copier, J., Lu, P.J., Cooper, L., Scibetta, A.G., Burchell, J., and Taylor-Papadimitriou, J. (2002). PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen? Int. J. Cancer 101, 581–588. Catteau, A., Rosewell, I., Solomon, E., and Taylor-Papadimitriou, J. (2004). A short region of the promoter of the breast cancer associated PLU-1 gene can regulate transcription in vitro and in vivo. Int. J. Oncol. 25, 5–16. Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., and Wicha, M.S. (2003). In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253–1270. Fang, D., Nguyen, T.K., Leishear, K., Finko, R., Kulp, A.N., Hotz, S., Van Belle, P.A., Xu, X., Elder, D.E., and Herlyn, M. (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65, 9328–9337. Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797–1806. Lu, P.J., Sundquist, K., Baeckstrom, D., Poulsom, R., Hanby, A., Meier-Ewert, S., Jones, T., Mitchell, M., Pitha-Rowe, P., Freemont, P., et al. (1999). A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274, 15633–15645. Roesch, A., Becker, B., Meyer, S., Wild, P., Hafner, C., Landthaler, M., and Vogt, T. (2005). Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod. Pathol. 18, 1249–1257. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., and Dirks, P.B. (2004). Identification of human brain tumour initiating cells. Nature 432, 396–401. Vogt, T., Kroiss, M., McClelland, M., Gruss, C., Becker, B., Bosserhoff, A.K., Rumpler, G., Bogenrieder, T., Landthaler, M., and Stolz, W. (1999). Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer. Lab. Invest. 79, 1615–1627. Wilsker, D., Probst, L., Wain, H.M., Maltais, L., Tucker, P.W., and Moran, E. (2005). Nomenclature of the ARID family of DNA-binding proteins. Genomics 86, 242–251. Yuan, X., Curtin, J., Xiong, Y., Liu, G., Waschsmann-Hogiu, S., Farkas, D.L., Black, K.L., and Yu, J.S. (2004). Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392–9400.